SCHEMBL7511558

SCHEMBL7511558

O=S(=O)(Nc1ccc2[nH]c(Cc3ccc(Oc4ccccc4)cc3)nc2c1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.72

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 12/20 0.72
GRIN2B Q13224 12/20 0.72
F2 P00734 1/20 0.51
AR P10275 2/20 0.51
NR3C1 P04150 1/20 0.50
PGR P06401 1/20 0.50
ESR2 Q92731 1/20 0.50
PTPN2 P17706 1/20 0.48
PTPN1 P18031 1/20 0.48
PTPN5 P54829 1/20 0.48
BRAF P15056 1/20 0.47
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
FFAR1 O14842 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7502977 0.90 GRIN1 (0.75) GRIN1GRIN2BF2ARPGR
SCHEMBL7512485 0.89 GRIN1 (0.77) GRIN1GRIN2BF2ARPGR
SCHEMBL7513211 0.88 GRIN1 (0.75) GRIN1GRIN2BF2PGRPTPN2
SCHEMBL7518591 0.88 GRIN1 (0.75) GRIN1GRIN2BF2ARPGR
SCHEMBL7510782 0.85 GRIN1 (0.64) GRIN1GRIN2BF2PTPN2PTPN1
SCHEMBL7517457 0.85 GRIN1 (0.66) GRIN1GRIN2BF2PTPN1SMN1; SMN2
SCHEMBL7448293 0.84 GRIN1 (1.00) GRIN1GRIN2BF2PGRALDH1A1
SCHEMBL7516788 0.83 GRIN1 (0.74) GRIN1GRIN2BF2PGRPTPN2
SCHEMBL7511360 0.83 GRIN1 (0.62) GRIN1GRIN2BF2
SCHEMBL7510373 0.83 GRIN1 (0.73) GRIN1GRIN2BF2PGRPTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242076-A4 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2002-11-27 EP disclosed
EP-1242076-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-09-25 EP disclosed
WO-2001032174-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed